NOVIGENIX

NOVIGENIX is an innovative Swiss molecular diagnostics company specializing in precision oncology solutions for the early detection of cancer, treatment optimization, and recurrence monitoring. Its main product, Colox®, is a validated molecular blood test designed to support the healthcare community in significantly reducing colorectal cancer mortality through early diagnosis and intervention. The company’s product portfolio leverages artificial intelligence and immunomics to provide actionable insights into the immune system's response to the onset of cancer and its evolution throughout the patient journey.